Tracking Technologies Guard Vaccine Cold Chain
Supply-chain visibility systems are proving their worth in the distribution of COVID-19 vaccines and may see broader use in the future.
Now that COVID-19 vaccines have received regulatory authorizations and vaccine manufacturers are providing a steady and increasing supply, the focus is on distributing doses. Vaccine manufacturers worked closely with cold-chain distribution experts to plan for maintaining and monitoring the cold chain for these crucial drug products. Pharmaceutical Technology spoke with Mahesh Veerina, CEO of Cloudleaf, and Gisli Herjolfssonn, CEO and cofounder of Controlant, about supply-chain visibility systems for maintaining the cold chain.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
About the Author
Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 38–43
Citation
When referring to this article, please cite it as J. Markarian, “Tracking Technologies Safeguard Vaccine Cold Chain" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
